Legal & General Group
SNNA

Legal & General Group’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Legal & General Group’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,188
Closed -$2K – 3475
2019
Q2 		$2K Hold
2,188
– – ﹤0.01% 3483
2019
Q1 		$5K Hold
2,188
– – ﹤0.01% 3317
2018
Q4 		$5K Hold
2,188
– – ﹤0.01% 3346
2018
Q3 		$32K Hold
2,188
– – ﹤0.01% 3003
2018
Q2 		$33K Sell
2,188
-464
-17% -$7.88K ﹤0.01% 2979
2018
Q1 		$50K Buy
2,652
+1,552
+141% +$27.1K ﹤0.01% 2758
2017
Q4 		$20K Buy
1,100
+449
+69% +$9.5K ﹤0.01% 3149
2017
Q3 		$14K Buy
+651
New +$14.3K ﹤0.01% 3246

Other funds holding SNNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $915M AUM 19.16% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return